Vaxcyte Newsroom

Alexandria Real Estate Equities, Inc. Announces Long-Term 258,581 RSF Lease With Longstanding Tenant Vaxcyte, Inc. at the Alexandria Center for Life Science - San Carlos Mega Campus

PR NewswireNov 21 16:10 ET

Vaxcyte Insider Sold Shares Worth $686,518, According to a Recent SEC Filing

MT NewswiresNov 19 16:53 ET

Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers

BenzingaNov 17 09:20 ET

RFK and the 'MAHA Trade': Vaccine Makers Down, Psychedelic Shares up

Seeking AlphaNov 15 06:02 ET

US MOVERS&SHAKERS Nov 11-Nov 15, 2024

Moomoo NewsNov 15 03:15 ET · Markets

"Anti-vaccine pioneer" nominated by Trump as Secretary of Health, vaccine stocks plummeted.

Trump nominated Robert F. Kennedy Jr. to be the Secretary of Health. Kennedy holds many unorthodox views in the field of public health, the most famous of which is questioning the safety and effectiveness of vaccines. He referred to vaccine injections as "crimes against humanity" during the COVID-19 pandemic and likened it to the Nazi Holocaust.

wallstreetcnNov 14 20:31 ET

Vaccine-maker Stocks Like Moderna, Pfizer Drop as Trump Picks RFK Jr. to Lead HHS

MarketWatchNov 14 16:40 ET

Vaxcyte Gets FDA Breakthrough Therapy Designation for Its Pneumococcal Disease Treatment

Seeking AlphaNov 12 08:59 ET

Express News | Vaxcyte Announces FDA Clearance for VAX-31 Infant Phase 2 Study and Breakthrough Therapy Designation for Adult Phase 3 Study

BenzingaNov 12 07:35 ET

Express News | Vaxcyte Inc: Expects to Initiate Vax-31 Infant Phase 2 Study by End of January 2025

ReutersNov 12 07:31 ET

Express News | Vaxcyte Inc: Vax-31 Infant Indication: Investigational New Drug Application Cleared by FDA

ReutersNov 12 07:31 ET

Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs

GlobeNewswireNov 12 07:30 ET

Express News | Vaxcyte Provides Positive Regulatory Updates on Vax-31 Pediatric and Adult Programs

ReutersNov 12 07:30 ET

We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely

Yahoo FinanceNov 7 06:32 ET

BofA Securities Maintains Vaxcyte(PCVX.US) With Buy Rating

Moomoo NewsNov 6 10:31 ET · Ratings

Express News | Cantor Fitzgerald Reiterates Overweight on Vaxcyte

BenzingaNov 6 09:43 ET

TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $135

Moomoo NewsNov 6 08:37 ET · Ratings

BTIG Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $160

Moomoo NewsNov 6 07:31 ET · Ratings

Needham Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $140

Moomoo NewsNov 6 06:33 ET · Ratings

Express News | Vaxcyte Inc : Jefferies Raises Target Price to $146 From $129

ReutersNov 6 03:41 ET